Circulating Monocytes as a Marker of Response to Adalimumab in Patients with Hidradenitis Suppurativa

    September 2024 in “ Dokumentenrepositorium der RUB (Ruhr University Bochum) ”
    Nessr Abu Rached, Jana Herbst, Thilo Gambichler … Falk G. Bechara
    Studysummary This study found that patients with higher baseline monocyte counts (\(\geq\) 925/\(\mu\)l) were significantly more likely to see treatment failure with adalimumab for hidradenitis suppurativa.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on hss-opus.ub.ruhr-uni-bochum.de →
    Discuss this study in the Community →